TG Therapeutics Investigational Trial Site

Katowice 40-684

1 studies enrolling now · 2 studies all time

What they study most

Relapsing Multiple Sclerosis, Relapsing Multiple Sclerosis (RMS)

Studies at this site

• Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab — Recruiting now
• An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis — Running, not enrolling